↑ 薬物リストへ　← 戻る

Theophylline er    (DrugBank: Theophylline)

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
236偽性副甲状腺機能低下症1

236. 偽性副甲状腺機能低下症　［臨床試験数：6，薬物数：4（DrugBank：2），標的遺伝子数：20，標的パスウェイ数：28］
Searched query = "Pseudohypoparathyroidism", "PHP", "PHP1a", "PHP1b", "PHP1c", "PHP2"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 6 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04240821
(ClinicalTrials.gov)		May 22, 202021/1/2020Theophylline for Treatment of PseudohypoparathyroidismOpen-Label Extension Study of Theophylline for Treatment of PseudohypoparathyroidismPseudohypoparathyroidism;Pseudohypoparathyroidism Type 1a;Albright Hereditary OsteodystrophyDrug: Theophylline ERAshley ShoemakerNULLEnrolling by invitation2 Years99 YearsAll34Phase 2United States